Table 3.
Parameter estimates in the AD population studied
| Base model | Final covariate model | |||
|---|---|---|---|---|
| Parameter | Value | RSE (%) | Value | RSE (%) |
| a) Fixed effects | ||||
| ka (h−1) | 0.377 | 8.8 | 0.385 | 8.8 |
| V2/F (l) | 653 | 2.3 | 649 | 2.2 |
| CLnon-met-male/F (l h−1) | 1.14 | 3.5 | 1.52 | 5.0 |
| CLnon-met-female/F (l h−1) | 1.14 | 3.5 | 1.16 | 5.8 |
| CLmet/F (l h−1) | 0.396 | 3.6 | 0.395 | 3.6 |
| V3/F (l) | 501.7 | – | 498.6 | – |
| CLM1/F (l h−1) | 0.936 | 3.7 | 0.925 | 3.6 |
| Base model | Final covariate model | |||
|---|---|---|---|---|
| Parameter | Value | RSE (%) | Value | RSE (%) |
| b) Covariate influence | ||||
| V2/F_WT (%)1 | n.a. | – | 1.06 | 14.9 |
| CLnon-met/F_CLCR (%)2 | n.a. | – | 1.17 | 20.9 |
| CLmet/F_WT (%)3 | n.a. | – | 0.31 | 30.6 |
| V3/F_BMI (%)4 | n.a. | – | 2.05 | 33.2 |
| V3/F_AGE (%)4 | n.a. | – | 1.41 | 18.7 |
| Base model | Final covariate model | |||
|---|---|---|---|---|
| Parameter | Value | RSE (%) | Value | RSE (%) |
| c) Random effects | ||||
| ωCLnon-met/F (CV%) | 76.9 | 14.5* | 70.2 | 16.1* |
| ωCLmet/F (CV%) | 24.3 | 12.4* | 23.6 | 13.2* |
| ωV2/F (CV%) | 36.1 | 15.2* | 30.5 | 13.8* |
| ωV3/F (CV%) | 35.9 | 11.2* | 33.2 | 12.7* |
| ωka (CV%) | 96.6 | 17.9* | 95.6 | 18.0* |
| Correlation | 0.66 | 17.8$ | 0.585 | 20.6$ |
| CLnon-met/F_V2/F | ||||
| prop. errNS2330 (%) | 19.4 | 11.6* | 19.4 | 11.6* |
| prop. errM1 (%) | 20.0 | 11.5* | 19.9 | 11.6* |
| add. errNS2330 (ng ml−1) | ±0.142 | 47.1* | ±0.146 | 45.9* |
V2/F = TVV2/Findividual × [1 + V2/F_WT × (WT-68.04)] × EXP(ωV2/F);
CLCR< 62.5 ml min−1: CLnon-met/Findividual = CLnon-met-sex/F × [1 + CLnon-met/F_CLCR × (CLCR − 62.5)] × EXP( ω CLnon-met/F) CLCR ≥ 62.5 ml min−1: CLnon-met/Findividual = CLnon-met-sex/F × EXP( ω CLnon-met/F);
CLmet/Findividual = CLmet/F × [1 − CLmet/F_WT × (WT − 68.04) × EXP( ω CLmet/F);
V3/Findividual = V3/F × [1 + V3/F_BMI × (BMI– 25.5)] × [1 + V3_AGE ×(AGE − 76)]×EXP( ω V2/F).
RSE is given on the variance scale
RSE of the covariance estimate.